Hannah Fry - 16 Jul 2022 Form 4 Insider Report for Protara Therapeutics, Inc. (TARA)

Role
VP, Controller
Signature
/s/ Mary Grendell, Attorney-in-Fact
Issuer symbol
TARA
Transactions as of
16 Jul 2022
Net transactions value
$0
Form type
4
Filing time
19 Jul 2022, 16:06:50 UTC
Next filing
04 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TARA Common Stock Award $0 +25,000 +962% $0.000000 27,600 16 Jul 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares being reported are being issued pursuant to a restricted stock unit (RSU) award, of which each RSU represents a contingent right to receive one share of Issuer's common stock. The RSUs vest one hundred percent (100%) on the first anniversary of July 16, 2022.